Cell-Based Methods for the Identification of Myc-Inhibitory Small Molecules

Catherine A Burkhart1, Michelle Haber2, Murray D Norris2

  • 1Buffalo BioLabs, Inc., Buffalo, NY, USA.

Insights

Researchers screened for small molecule inhibitors targeting the Myc family of transcription factors, which are crucial for tumor maintenance. This cell-based approach aims to overcome the challenge of targeting "undruggable" oncogenic transcription factors for cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Oncoproteins from dominant oncogenes are established chemotherapeutic targets.
  • Oncogenic transcription factors, like Myc, are essential for tumor cell survival but historically considered difficult to target.
  • The Myc family of transcription factors is implicated in the maintenance of most tumor types.

Purpose of the Study:

  • To develop cell-based methods for identifying small molecule inhibitors of c-Myc.
  • To screen diverse chemical libraries for compounds that specifically inhibit Myc functionality.

Main Methods:

  • Utilized cell-based screening assays.
  • Employed diverse small molecule libraries.
  • Focused on Myc functionality and specificity for inhibitor identification.

Main Results:

  • Successfully developed and applied cell-based approaches to identify potential c-Myc inhibitors.
  • Demonstrated the feasibility of screening for inhibitors targeting oncogenic transcription factors.

Conclusions:

  • Cell-based screening offers a viable strategy for discovering inhibitors of challenging targets like c-Myc.
  • This approach holds promise for developing novel cancer chemotherapeutics targeting Myc-dependent tumors.

Related Concept Videos